Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders
Katja Maurus, Silke Appenzeller, Sabine Roth, Stephanie Brändlein, Hermann Kneitz, Matthias Goebeler, Andreas Rosenwald, Eva Geissinger, Marion Wobser
Topics & Concepts
Lymphoproliferative disordersstatCD30JAK-STAT signaling pathwayMedicineCancer researchImmunologyLymphomaPathologyBiologyInternal medicineReceptorSignal transductionTyrosine kinaseSTAT3BiochemistryCutaneous lymphoproliferative disorders researchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research